Difficulty: Medium
Average Score: 83%
Practice
Sulfonylurea hypoglycaemics act by
Correct answer
D
Rationale
Sulfonylurea hypoglycemic agents are a class of drugs commonly used to treat type 2 diabetes by lowering blood sugar levels. The correct answer to the question is D) Both (b) and (c), which means that sulfonylureas act by increasing insulin secretion from the pancreas and reversing down-regulation of insulin receptors.
1. Increasing insulin secretion from the pancreas: Sulfonylureas work by stimulating the beta cells in the pancreas to release more insulin. This helps to lower blood glucose levels by increasing the amount of insulin available to facilitate the uptake of glucose by cells for energy production.
2. Reversing down-regulation of insulin receptors: In diabetes, there is often a decrease in the sensitivity of cells to insulin due to down-regulation of insulin receptors. Sulfonylureas help to reverse this down-regulation, making cells more responsive to insulin and improving glucose uptake.
Now, let's discuss why the other options are incorrect:
A) Reducing intestinal absorption of glucose: This option is not correct because sulfonylureas do not act on the intestines to reduce the absorption of glucose. Their primary mechanism of action is at the pancreatic level to increase insulin release.
C) Reversing down-regulation of insulin receptors: This option is partially correct, but it alone does not encompass the full mechanism of action of sulfonylureas. While sulfonylureas do help reverse down-regulation of insulin receptors, they also work by increasing insulin secretion from the pancreas, as mentioned in option D.
Educational context: Understanding how sulfonylureas work is crucial for healthcare professionals managing patients with diabetes. By knowing the mechanism of action, healthcare providers can make informed decisions about treatment options, potential side effects, and how to monitor and adjust therapy for optimal patient outcomes. This knowledge also helps in educating patients about their medications and the importance of adherence to treatment plans for effective diabetes management.
1. Increasing insulin secretion from the pancreas: Sulfonylureas work by stimulating the beta cells in the pancreas to release more insulin. This helps to lower blood glucose levels by increasing the amount of insulin available to facilitate the uptake of glucose by cells for energy production.
2. Reversing down-regulation of insulin receptors: In diabetes, there is often a decrease in the sensitivity of cells to insulin due to down-regulation of insulin receptors. Sulfonylureas help to reverse this down-regulation, making cells more responsive to insulin and improving glucose uptake.
Now, let's discuss why the other options are incorrect:
A) Reducing intestinal absorption of glucose: This option is not correct because sulfonylureas do not act on the intestines to reduce the absorption of glucose. Their primary mechanism of action is at the pancreatic level to increase insulin release.
C) Reversing down-regulation of insulin receptors: This option is partially correct, but it alone does not encompass the full mechanism of action of sulfonylureas. While sulfonylureas do help reverse down-regulation of insulin receptors, they also work by increasing insulin secretion from the pancreas, as mentioned in option D.
Educational context: Understanding how sulfonylureas work is crucial for healthcare professionals managing patients with diabetes. By knowing the mechanism of action, healthcare providers can make informed decisions about treatment options, potential side effects, and how to monitor and adjust therapy for optimal patient outcomes. This knowledge also helps in educating patients about their medications and the importance of adherence to treatment plans for effective diabetes management.